Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00026646
DRKS00026646
Not yet recruiting
Not Applicable

Identification of Biological and Psychosocial Factors of Symptom Persistence in Pruritus - SOMACROSS-Pruritus-4

Kompetenzzentrum Chronischer Pruritus, Klinik für Hautkrankheiten, Universitätsklinikum Münster0 sites200 target enrollmentSeptember 17, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsL20.8L29.8L29.9Other atopic dermatitisOther pruritusPruritus, unspecified

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
L20.8
Sponsor
Kompetenzzentrum Chronischer Pruritus, Klinik für Hautkrankheiten, Universitätsklinikum Münster
Enrollment
200
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 17, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Kompetenzzentrum Chronischer Pruritus, Klinik für Hautkrankheiten, Universitätsklinikum Münster

Eligibility Criteria

Inclusion Criteria

  • •Age \= 18 years
  • •Group 1: Acute atopic dermatits (aAD)
  • •acute eczema \= 4 weeks at baseline
  • •previous eczema free interval for at least 6 months
  • •pruritus intensity (NRS worst pruritus of the last 24h): \=5/10
  • •Group 2: chronic atopic dermatitis (cAD)
  • •clinical diagnosis of atopic dermatitis, for at least 6 months
  • •chronic pruritus (\= 6 weeks duration)
  • •pruritus intensity (NRS worst pruritus of the last 24h): \=5/10
  • •Group 3: chronic pruritus on non\-lesional skin (CPNL)

Exclusion Criteria

  • •\- Acute exacerbation of a dermatosis (exception: atopic dermatitis) or cutaneous infection
  • •\- pregnancy, breastfeeding
  • •\- drug or alcohol abuse
  • •\- allergy against local anesthetics
  • •\- Tendency of developing keloids
  • •\- Chronic pain, fibromyalgia
  • •\- Intake of antihistamines, systemic steroids, systemic immunosuppressants, gabapentinoids or analgesics in the previous 4 weeks (intake of antidepressants is allowed if not as antipruritic medication).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Identification of psychometric and biological markers to assess androgen and serotonergic sensitivity in relation to sexual functioning in women.Female Sexual DysfunctionHypoactive Sexual Desire Disorder10013356
NL-OMON34558Emotional Brain200
Completed
Not Applicable
The influence of Pilates on the strength and functionality of the elderly
RBR-24z8q24niversidade Federal de Santa Maria
Completed
Not Applicable
Verification of the diagnosis and the psychosocial intervention for individuals with developmental disordersdevelopmental disorders
JPRN-UMIN000002584Department of Childpsychiatry, University of Tokyo Hospital20
Not yet recruiting
Phase 1
Assessment of self reported physical symptoms, stress and anxiety social support, coping strategies among women carrier for hemophilia
CTRI/2018/08/015268Bayer Consumer Care AG
Completed
Not Applicable
Research on mental and physical conditions detected by heart rate variability analysis
JPRN-UMIN000046352Kanazawa University140